πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 812 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9062297

Yersinia pestis vaccine

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9056068

Vaccine and methods of use against Strongyloide stercoralis infection

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9044419

Vaccine compositions compromising Ξ²s-crystallin for inducing immune responses against comp

Northwestern University Β· Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9028809

Compositions, methods and uses for expression of enterobacterium-associated peptides

Takeda Vaccines, Inc. Β· Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9011874

Compositions, methods and uses for poxvirus elements in vaccine constructs

Takeda Vaccines, Inc. Β· Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9005633

Psoralen-inactivated viral vaccine and method of preparation

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9005632

Compositions, methods and uses for poxvirus elements in vaccine constructs against influen

Takeda Vaccines, Inc. Β· Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9005631

Membrane proximal region of HIV gp41 anchored to the lipid layer of a virus-like particle

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8992943

Vaccine for protection against Shigella sonnei disease

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8992944

Purified Plasmodium and vaccine composition

Sanaria Inc. Β· Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8986708

Combinations of gene deletions for live attenuated Shigella vaccine strains

The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research Β· Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8980275

Targeted heterologous antigen presentation on calicivirus virus-like particles

Takeda Vaccines, Inc. Β· Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8968719

Live, oral vaccine for protection against Shigella dysenteriae serotype 1

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8968996

Compositions and methods for rapid immunization against dengue virus

Takeda Vaccines, Inc. Β· Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8961996

N-linked glycosylation alteration in E0 and E2 glycoprotein of classical swine fever virus

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8927692

Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses

Inovio Pharmaceuticals, Inc. Β· Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8926986

Use of saccharides cross-reactive with Bacillus anthracis spore glycoprotein as a vaccine

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8920812

Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS

Takeda Vaccines, Inc. Β· Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8921536

HCV vaccines and methods for using the same

Inovio Pharmaceuticals, Inc. Β· Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8916175

Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of inf

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8916519

Influenza A virus vaccines and inhibitors

The Board of Regents of the University of Texas System Β· Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8900599

Conjugates of Plasmodium falciparum surface proteins as malaria vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8877208

Multivalent nanoemulsion vaccines

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8877213

Live attenuated Leishmania vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted